Analysis Note
ControlU251 cells
Application
Research Sub CategoryNeuronal & Glial Markers
Research CategoryNeuroscience
Milli-Mark Anti-MAP2-PE Antibody, clone AP20 is an antibody against MAP2 for use in FC.
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
General description
MAP-2 (microtubule associated protein-2) is one of several high molecular weight proteins that play an important role in brain neuron microtubule assembly. In addition to its association with microtubules, MAP-2 associates with neurofilaments and actin filaments suggesting that it may guide interaction among microtubules, other cytoskeletal elements, and cytoplasmic organelles. MAP-2 is a stringent marker for neurons. In addition, MAP-2 displays intracellular specificity. In the central nervous system, MAP-2 is confined to neuronal cell bodies and dendrites. There are exceptions, however, where some axons stain positive for small amounts of MAP-2. MAP-2 is uniformly distributed throughout the cell when first expressed in cultured neurons but becomes selectively localized as dendritic development proceeds. (Caceres, 1986; Dotti, 1987).
Immunogen
Recombinant Bovine brain microtubule protein.
Legal Information
MILLI-MARK is a registered trademark of Merck KGaA, Darmstadt, Germany
Physical form
Protein A purified
Purified mouse monoclonal IgG1 conjugated to PE in PBS with 0.1% sodium azide and 15 mg/mL BSA.
Quality
Evaluated by flow cytometry using U251 cells
Specificity
Antibody recognizes MAP-2.
Storage and Stability
Maintain refrigerated at 2-8°C protected from light for up to 6 months from date of receipt.
Target description
199.5 kDa Calculated
This product has met the following criteria to qualify for the following awards: